Fennec Pharmaceuticals Ownership | Who Owns Fennec Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Fennec Pharmaceuticals Ownership Summary

Fennec Pharmaceuticals is owned by 56.60% institutional investors, 14.39% insiders, and 29.01% retail investors. Rosalind advisors is the largest institutional shareholder, holding 10.18% of FENC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.20% of its assets in Fennec Pharmaceuticals shares.

FENC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Fennec Pharmaceuticals	56.60%	14.39%	29.01%
Sector	Healthcare Stocks	35.49%	11.75%	52.76%
Industry	Biotech Stocks	34.83%	11.71%	53.46%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rosalind advisors	2.91M	10.18%	$17.89M
Southpoint capital advisors lp	2.74M	9.60%	$16.88M
Sonic gp	2.41M	8.80%	$15.21M
Solas capital management	2.48M	8.69%	$15.27M
Aigh capital management	1.98M	6.93%	$12.19M
Blackrock funding, inc. /de	1.37M	4.79%	$8.41M
Blackrock	1.19M	4.39%	$7.25M
Vanguard group	1.07M	3.83%	$8.22M
Awm investment company	720.13K	2.52%	$4.43M
Geode capital management	371.74K	1.30%	$2.29M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sonic gp	2.41M	33.54%	$15.21M
Solas capital management	2.48M	8.78%	$15.27M
Rosalind advisors	2.91M	7.19%	$17.89M
Lion point capital, lp	112.43K	4.13%	$691.47K
Aigh capital management	1.98M	1.66%	$12.19M
Potomac capital management	224.40K	1.20%	$1.38M
Awm investment company	720.13K	0.49%	$4.43M
Southpoint capital advisors lp	2.74M	0.35%	$16.88M
Nano cap new millennium growth fund l p	21.50K	0.12%	$132.22K
Tang capital management	334.59K	0.12%	$3.13M

Top Buyers

Holder	Shares	% Assets	Change
Aigh capital management	1.98M	1.66%	400.00K
Tang capital management	334.59K	0.12%	314.07K
Rosalind advisors	2.91M	7.19%	294.69K
Blackrock	1.19M	0.00%	259.78K
Blackrock funding, inc. /de	1.37M	0.00%	133.90K

Top Sellers

Holder	Shares	% Assets	Change
Apis capital advisors	-	-	-204.00K
Harbert fund advisors	-	-	-177.81K
Essex investment management	-	-	-144.22K
Marshall wace, llp	-	-	-127.69K
Dg capital management	-	-	-84.21K

New Positions

Holder	Shares	% Assets	Change	Value
Cornerstone capital	105.00K	0.06%	105.00K	$645.75K
Thompson siegel & walmsley	57.23K	0.01%	57.23K	$352.00K
Eleva capital sas	53.23K	0.10%	53.23K	$327.39K
Vanguard fiduciary trust	38.72K	0.00%	38.72K	$238.15K
Prelude capital management	29.60K	0.01%	29.60K	$182.03K

Sold Out

Holder	Change
Newedge advisors	-1.00
Sbi securities	-1.00
Nelson, van denburg & campbell wealth management group	-3.00
Capital performance advisors llp	-5.00
Toronto dominion bank	-25.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	87	-8.42%	16,173,789	4.09%	56	1.82%	51	10.87%	18	-25.00%
Dec 31, 2025	41	-50.60%	7,252,139	-47.69%	26	1.04%	16	-57.89%	9	-62.50%
Sep 30, 2025	37	-48.61%	3,501,549	-73.61%	12	0.55%	10	-73.68%	12	-45.45%
Jun 30, 2025	77	13.24%	13,599,983	1.57%	49	2.09%	40	33.33%	24	20.00%
Mar 31, 2025	5	-92.19%	4,328,394	-73.03%	15	0.46%	2	-94.87%	1	-92.31%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	882.05K	3.20%	5.84K
Vanguard Total Stock Mkt Idx Inv	873.03K	2.53%	-
iShares Russell 2000 ETF	598.02K	1.72%	5.03K
Fidelity Small Cap Index	225.72K	0.65%	1.23K
iShares Russell 2000 Value ETF	168.92K	0.49%	910.00
State St Russell Sm/Mid Cp® Indx NL Cl C	122.70K	0.44%	-
Russell 2000 Equity Index Fund B	144.30K	0.42%	-74.00
Vanguard Russell 2000 ETF	143.33K	0.42%	27.67K
State St Russell Sm/Mid Cp® Indx SL Cl I	125.70K	0.36%	-
Bridgeway Ultra-Small Company	83.00K	0.24%	52.30K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 11, 2026	RALLIS CHRIS A	-	Sell	$58.76K
May 01, 2026	Raykov Rosty	-	Sell	$69.75K
Apr 01, 2026	Raykov Rosty	-	Sell	$69.07K
Mar 02, 2026	Raykov Rosty	-	Sell	$84.26K
Feb 02, 2026	Raykov Rosty	-	Sell	$80.31K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	3
2026 Q1	-	3
2025 Q4	-	11
2025 Q3	-	4
2024 Q4	-	1

FENC Ownership FAQ

Who Owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals shareholders are primarily institutional investors at 56.60%, followed by 14.39% insiders and 29.01% retail investors. The average institutional ownership in Fennec Pharmaceuticals's industry, Biotech Stocks , is 34.83%, which Fennec Pharmaceuticals exceeds.

Who owns the most shares of Fennec Pharmaceuticals?

Fennec Pharmaceuticals’s largest shareholders are Rosalind advisors (2.91M shares, 10.18%), Southpoint capital advisors lp (2.74M shares, 9.60%), and Sonic gp (2.41M shares, 8.80%). Together, they hold 28.58% of Fennec Pharmaceuticals’s total shares outstanding.

Does Blackrock own Fennec Pharmaceuticals?

Yes, BlackRock owns 4.39% of Fennec Pharmaceuticals, totaling 1.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.25M$. In the last quarter, BlackRock increased its holdings by 259.78K shares, a 28.01% change.

Who is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sonic gp is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 33.54% of its assets in 2.41M Fennec Pharmaceuticals shares, valued at 15.21M$.

Who is the top mutual fund holder of Fennec Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Fennec Pharmaceuticals shares, with 3.20% of its total shares outstanding invested in 882.05K Fennec Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools